These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
498 related articles for article (PubMed ID: 17904316)
1. Development of PEGylated adenovirus vector with targeting ligand. Eto Y; Yoshioka Y; Mukai Y; Okada N; Nakagawa S Int J Pharm; 2008 Apr; 354(1-2):3-8. PubMed ID: 17904316 [TBL] [Abstract][Full Text] [Related]
2. Effective tumor targeted gene transfer using PEGylated adenovirus vector via systemic administration. Gao JQ; Eto Y; Yoshioka Y; Sekiguchi F; Kurachi S; Morishige T; Yao X; Watanabe H; Asavatanabodee R; Sakurai F; Mizuguchi H; Okada Y; Mukai Y; Tsutsumi Y; Mayumi T; Okada N; Nakagawa S J Control Release; 2007 Sep; 122(1):102-10. PubMed ID: 17628160 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses. Mok H; Palmer DJ; Ng P; Barry MA Mol Ther; 2005 Jan; 11(1):66-79. PubMed ID: 15585407 [TBL] [Abstract][Full Text] [Related]
4. PEGylated adenovirus for targeted gene therapy. O'Riordan CR; Song A Methods Mol Biol; 2008; 434():133-60. PubMed ID: 18470643 [TBL] [Abstract][Full Text] [Related]
5. The influence of adenovirus fiber structure and function on vector development for gene therapy. Nicklin SA; Wu E; Nemerow GR; Baker AH Mol Ther; 2005 Sep; 12(3):384-93. PubMed ID: 15993650 [TBL] [Abstract][Full Text] [Related]
7. Host responses and persistence of vector genome following intrabronchial administration of an E1(-)E3(-) adenovirus gene transfer vector to normal individuals. Harvey BG; Hackett NR; Ely S; Crystal RG Mol Ther; 2001 Feb; 3(2):206-15. PubMed ID: 11237677 [TBL] [Abstract][Full Text] [Related]
8. Adenovirus vector-mediated gene transfer into stem cells. Kawabata K; Sakurai F; Koizumi N; Hayakawa T; Mizuguchi H Mol Pharm; 2006; 3(2):95-103. PubMed ID: 16579638 [TBL] [Abstract][Full Text] [Related]
9. Gene therapy progress and prospects: adenoviral vectors. St George JA Gene Ther; 2003 Jul; 10(14):1135-41. PubMed ID: 12833122 [TBL] [Abstract][Full Text] [Related]
10. Modification of pIX or hexon based on fiberless Ad vectors is not effective for targeted Ad vectors. Kurachi S; Koizumi N; Tashiro K; Sakurai H; Sakurai F; Kawabata K; Nakagawa S; Mizuguchi H J Control Release; 2008 Apr; 127(1):88-95. PubMed ID: 18258327 [TBL] [Abstract][Full Text] [Related]